Filter
956
Text search:
ncov
Featured
Recommendations
202
New Publications
3
Language
Document type
Guidelines
531
Fact sheets
119
Studies & Reports
110
Manuals
74
Strategic & Response Plan
36
Infographics
23
Training Material
15
Situation Updates
12
Resource Platforms
10
Online Courses
9
No document type
9
Brochures
7
Videos
1
Countries / Regions
Russia
81
Brazil
59
Middle East and North Africa
48
Latin America and the Carribbean
40
Syria
34
Global
34
West and Central Africa
31
Mozambique
30
Yemen
29
Germany
27
Angola
27
Eastern Europe and Central Asia
26
Western and Central Europe
23
Africa
22
East and Southern Africa
19
Guinea-Bissau
17
South Sudan
16
Spain
13
India
11
South Africa
9
South–East Asia Region
9
Eastern Europe
9
Peru
8
Colombia
8
Chile
8
Vietnam
8
China
7
El Salvador
7
Paraguay
7
Kenya
6
Ukraine
6
Ecuador
6
Italy
6
Portugal
6
Nigeria
5
Sudan
5
Argentina
5
Saudi Arabia
4
Cambodia
4
Bangladesh
4
Western Pacific Region
4
Niger
3
Philippines
3
Iraq
3
Chad
3
Indonesia
3
Bolivia
3
Laos
3
France
3
Burkina Faso
2
Mali
2
Ethiopia
2
Cameroon
2
Somalia
2
Lebanon
2
Turkey
2
Singapore
2
Honduras
2
Guatemala
2
Kazakhstan
2
Japan
2
South Korea
2
Belarus
2
Guinea
1
Sierra Leone
1
Senegal
1
Congo, Democratic Republic of
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Togo
1
Zimbabwe
1
Haiti
1
Jordan
1
Egypt
1
Tanzania
1
Thailand
1
Malaysia
1
Mauritania
1
Ireland
1
Malawi
1
Benin
1
Central African Republic
1
Dominican Republic
1
Austria
1
Switzerland
1
Cuba
1
Burundi
1
Libya
1
Madagascar
1
Mexico
1
Nicaragua
1
Myanmar / Burma
1
Luxembourg
1
Asia
1
Venezuela
1
North Korea
1
Djibouti
1
Congo-Brazzaville
1
Canada
1
Qatar
1
Australia
1
Belgium
1
Mauritius
1
Tunisia
1
Algeria
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
425
Key Resources
27
Women & Child Health
21
Clinical Guidelines
19
Pharmacy & Technologies
15
Public Health
11
Capacity Building
7
Toolboxes
COVID-19
853
Mental Health
16
Rapid Response
14
Caregiver
13
HIV
10
2.0 Rapid Response
8
Refugee
6
Planetary Health
6
TB
5
Conflict
4
Pharmacy
4
Zika
3
Health Financing Toolbox
3
Ebola & Marburg
2
Polio
2
AMR
2
Natural Hazards
1
Global Health Education
1
NTDs
1
NCDs
1
For most people in displacement contexts, there are simply not enough vaccines available in the places where they are hosted: 85% of refugees are hosted in lower- and middle-income countries, while in the first six months of this year 85% of vaccines went to wealthy countries; lower- and middle inco
...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
The rapid assessment tool (RAT) is meant to assess health facilities within mpox-affected areas that have at least one inpatient bed. Depending on time and resources available, certain facilities may be prioritized during an mpox outbreak. The RAT evaluates 16 infection prevention and control (IPC)
...
This document provides interim guidance on the management of the blood supply in response to the pandemic outbreak of coronavirus disease (COVID-19). It emphasizes the importance of being prepared and responding quickly and outlines key actions and measures that the blood services should take to mit
...
At the global, national, and regional levels, there are several guidelines and guides regarding the preparedness, prevention, surveillance, and control of diseases caused by respiratory viruses; most initiatives focus on specific virus events or cases. During the coronavirus disease 2019 (COVID-19)
...
The COVID-19 Vaccine (Whole Virion Inactivated) BBV152, COVAXIN® vaccine explainer includes key information on the vaccine specific requirements.
Consolidated recommendations for palliative care in the SARS pandemic-Cov-2/COVID-19 2020
This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO and other public health agencies.
his Inter Action Review report for the COVID-19 outbreak in Mauritius documents and assesses the country’s capacity to respond to the outbreak and identifies the best practices, strengths, gaps and challenges of the national response. Areas requiring improvements or sustained actions have been ide
...
COVID-19 is a pandemic that is currently ravaging the world. Infection rate is steadily increasingin Sub-Saharan Africa. Pregnant women and their infants may suffer severe illnesses due to theirlower immunity. This guideline prepares and equips clinicians working in the maternal and new-born section
...
This document sets out the preparedness and response plan of the Nigerian Primary Health Care System for COVID-19 Acute Respiratory Disease. It outlines the planning scenarios, key areas of work and priority activities required for the Primary Health Care Sector to quickly scale up its core capacity
...
In response to the COVID-19 outbreak, this guidance provides information on infection and prevention control (IPC) for older people, their friends and families, carers, and healthcare providers. Anyone who manages, works, volunteers or provides care at any type of facilities where older people recei
...
This brief considers the rationale for shielding individuals at high risk of severe disease or death from COVID-19 in low- and middleincome countries. It provides an overview of proposed approaches to shielding, discusses the categories of individuals who may be identified for shielding, and outline
...
Available in Arabic, Chinese, English, French, Portuguese, Russian and Spanish
https://apps.who.int/iris/handle/10665/334254
orientations provisoires, première publication: 10 février 2021, mise à jour : 21 avril 2021, dernière mise à jour : 30 juillet 2021
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th
...
Über SARS-CoV-2-Testsysteme informieren das Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) und das Paul-Ehrlich-Institut. Die Informationen ergänzen sich, den rechtlichen Rahmen bietet u.a. die Coronavirus-Testverordnung-TestV.
Das BfArM bietet eine Liste von Antigen-Tests zum dir
...
